University of Michigan Rogel Cancer Center
2 clinical trials · 2 recruiting · OTHER
Trials by University of Michigan Rogel Cancer Center
RECRUITINGPhase 2NCT03099356
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
This study will be a non-randomized pilot trial using Cyclophosphamide and Sirolimus for the treatment of metastatic differentiated thyroid cancer. Patients will be treated with...
Sponsor: University of Michigan Rogel Cancer CenterEnrolling: 221 location
Metastatic Thyroid Cancer
RECRUITINGNCT05653388
Metastatic Leiomyosarcoma Biomarker Protocol
Leiomyosarcoma (LMS) is one of the most prevalent soft tissue sarcomas (STS) and can occur in various sites including soft tissue, uterus and retroperitoneal large vessels....
Sponsor: University of Michigan Rogel Cancer CenterEnrolling: 20011 locations
Leiomyosarcoma